The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. Multiple strategies are employed enhance antibody titer, including process parameter optimization, media optimization, and the use of perfusion technologies. Fine-tuning growth parameters plays a c